Natco Pharma Rights Issue LOF Approved at Rs 750 Per Share

Corporate Actions View source PDF Explain this filing

NATCOPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.8%Reaction day

₹828.00

prior close

₹832.45

announcement price

After-mkt

timing

Nifty Smallcap 250market-0.6%+2.4% vs market

Pharmaceuticals peers, median of 173sector+0.4%+1.4% vs sector

On the reaction day the stock moved 2.4 pts more than Nifty Smallcap 250 and 1.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.4

10m

-0.3

15m

+0.3

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.8-0.6+2.4+0.4+1.4

Next day

-0.2-0.4+0.1-0.4+0.1

-1.1-1.5+0.4-1.4+0.3

-0.7-1.2+0.4-1.6+0.9

-0.5+0.2-0.7-1.1+0.6

-2.1+0.3-2.4-1.1-1.0

-4.6-1.6-3.0-3.2-1.4

15d

-5.1-5.6+0.6-7.3+2.2

-5.0-4.3-0.7-5.2+0.3

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Natco Pharma's Fund Raising Committee approved the Letter of Offer for a Rights Issue of up to 1.7 crore equity shares at Rs 750 per share, aggregating up to Rs 1,279.4 crore. Ratio: 2 rights shares for every 21 held. Record date October 1, 2026; issue opens October 12 and closes October 22, 2026. Listing expected by October 27.

Likely market impact

Eligible shareholders can subscribe at Rs 750 per share; dilutes equity base by around 9.5 percent. Short-term price pressure possible.